Renaissance Capital logo

NRx Pharmaceuticals (Big Rock Partners Acquisition) Priced, Nasdaq: NRXP

Blank check company formed to acquire a business in the senior housing and care industry (completed 5/24/2021).

Industry: SPAC

First Day Return: +0.1%

Industry: SPAC

We are a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. We intend to initially focus our search on identifying a prospective target business in the senior housing and care industry in the United States. We do not have any specific business combination under consideration and we have not had any substantive discussions, formal or otherwise, with respect to such a transaction. In the US, there currently are approximately 23,400 investment grade senior housing and care properties containing 3 million units. Our Chairman, President and CEO, Richard Ackerman, has over 35 years of real estate experience with 18 years in senior housing. In 2004, Ackerman founded Big Rock Partners, an opportunistic real estate investment firm founded that has invested in and managed over $800 million in assets since its formation.
more less
IPO Data
IPO File Date 10/13/2017
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 6.0
Deal Size ($mm) $60
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 11/20/2017
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $60
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Delray Beach, FL, United States
Founded 2017
Employees at IPO 3
Website www.bigrockpartners.com

NRx Pharmaceuticals (Big Rock Partners Acquisition) (NRXP) Performance